Stock Screener App

Frei -

Installieren

Drug Manufacturers - Specialty & Generic

0.92

9.01% -0.0911

after-market

Handel nachbörslich: .92

Gelteq Ltd (GELS)

Überblick Nachrichten Preisverlauf Forum Prognose

Gelteq Ltd Aktie (GELS) Neueste Nachrichten

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

CNS Pharma Stock Price, Quotes and Forecasts | NASDAQ:CNSP - Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Athira Pharma Stock Price, Quotes and Forecasts | NASDAQ:ATHA - Benzinga

Addex Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ADXN - Benzinga

Gelteq introduces SportsGel with China deal in H1 2025 - Investing.com India

Gelteq introduces SportsGel with China deal in H1 2025 By Investing.com - Investing.com South Africa

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Gelteq Appoints Matthew Jones as Head of Sports Performance - GlobeNewswire Inc.

Gelteq Taps UAE Football, Boston Celtics Nutrition Expert to Lead Sports Performance Division - StockTitan

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Gelteq Strengthens Leadership with Renowned Scientist Dr. Paul Wynne as Chief Scientific Officer - StockTitan

“Gelteq has been continuously evolving to expand applications and audiences” - AlphaStreet

Gelteq Receives FDA Approval of its Suitability Petition for New Animal Drug - The Manila Times

Why C3.ai Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga

Gelteq CEO to Present at Benchmark's Discovery Investor Conference - StockTitan

The Benchmark Company Announces Upcoming Discovery One-on-One Investor Conference - The Manila Times

Why Credo Technology Group Shares Are Trading Higher By 40%; Here Are 20 Stocks Moving Premarket - Inkl

Oral drug and nutrient gel specialist soars after top client bumps up order by 50% - Mugglehead

NovoCure Limited (NASDAQ: NVCR): Groundbreaking PANOVA-3 Trial Results Signal Hope for Pancreatic Cancer Patients - BP Journal

Gelteq Limited (NASDAQ: GELS): Transforming Nutraceuticals with Gel-Based Innovation and Strategic U.S. Expansion - BP Journal

The Ascending Trajectory of Purple Biotech Ltd (PPBT): Pioneering Pancreatic Cancer Treatment with CM24 - BP Journal

Senti Biosciences, Inc. (SNTI) could keep surging and here’s why - BP Journal

Stock market news: Senti Biosciences +404.62%, Fossil Group +54.11% among top gainers during mid day trading - Business Upturn

Polyrizon Ltd.’s Quiet Period To End on December 9th (NASDAQ:PLRZ) - Defense World

Gelteq Limited’s (NASDAQ:GELS) Quiet Period To End on December 9th - Defense World

Gelteq (GELS) Ramps Up Production: 400,000 Gel Units Set for Global Distribution | GELS Stock News - StockTitan

Ins & OutsWeek Ending 11/15/2024 - substack.com

Gelteq Limited Appoints Adam Bendell as President of U.S. Operations - Marketscreener.com

Gelteq (GELS) Accelerates U.S. Growth, Appoints Former Deloitte Executive as President - StockTitan

Med-tech funding rises, driven by private investments and follow-ons - BioWorld Online

Gelteq Closes $5.2M IPO By Investing.com - Investing.com Australia

Gelteq launches IPO, raises $5.2 million for expansion - Investing.com India

Gelteq Limited Closes US$5.2 Million Initial Public Offering - The Manila Times

GELSGelteq Limited Ordinary Shares Latest Stock News & Market Updates - StockTitan

Argent Biopharma Lists New Shares on ASX - MSN

Biotech company Gelteq prices IPO at $4 per share - MSN

Vietnam Manufacturing & Export Processing to Announce Quarterly Results - MSN

Maas Group Reports Record Results and Growth Strategy - MSN

Qualitas Limited Releases 2024 Governance Statement - MSN

Biotech company Gelteq prices IPO at $4 per share (NASDAQ:GELS) - Seeking Alpha

WiseTech Investor Urges Progress, Transparency Amid CEO Scandal - MSN

Novatti Group Announces Hybrid Annual General Meeting - MSN

Gelteq Limited Prices US$5.2 Million Initial Public Offering - The Manila Times

RooLife Group Announces AGM with Key Resolutions - MSN

Ingram Micro IPO: Major tech product distributor debuts on NYSE today after pricing its stock within target range - MSN

Strike Resources Limited Announces Upcoming AGM Details - MSN

IPO Roundup: Ingram Micro Holdings, Peak Resources and more (NYSEARCA:IPO) - Seeking Alpha

Nathan Givoni & Simon Szewach on Gelteq - The Good Men Project

Aldebaran Financial Inc. Purchases 710 Shares of Invesco QQQ (NASDAQ:QQQ) - Defense World

SkyView Investment Advisors LLC Boosts Stock Holdings in General Electric (NYSE:GE) - Defense World

Mira Pharmaceuticals (NASDAQ:MIRA) Stock Quotes, Forecast and News Summary - Benzinga

Redhill Biopharma (NASDAQ:RDHL) Stock Quotes, Forecast and News Summary - Benzinga

Diabetes Assays Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies - GlobalData

AST SpaceMobile registers shares in Antares reorg - MSN

Kiora Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:KPRX - Benzinga

AN2 Therapeutics (NASDAQ:ANTX) Stock Quotes, Forecast and News Summary - Benzinga

ELAN

$9.72

9.75%

ALKS

$31.66

3.03%

LNTH

$97.21

0.22%

VTRS

$8.16

5.77%

NBIX

$102.88

5.01%

UTHR

$307.36

1.57%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters